Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Authors: Robert J. Motzer, Thomas E. Hutson, Hilary Glen, M. Dror Michaelson, Ana M. Molina, Timothy Eisen, Jacek Jassem, Jakub Żołnierek, Jose Pablo Maroto, Begoña Mellado, Bohuslav Melichar, Jiří Tomášek, Alton B. Kremer, Hanjoo Kim, Karen Wood, Corina E. Dutcus, James Larkin - The Lancet 2015 cited by 943